Product NDC: | 25021-107 |
Proprietary Name: | Ceftriaxone |
Non Proprietary Name: | ceftriaxone |
Active Ingredient(s): | 2 g/1 & nbsp; ceftriaxone |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-107 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065329 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091105 |
Package NDC: | 25021-107-20 |
Package Description: | 25 VIAL in 1 CARTON (25021-107-20) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
NDC Code | 25021-107-20 |
Proprietary Name | Ceftriaxone |
Package Description | 25 VIAL in 1 CARTON (25021-107-20) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Product NDC | 25021-107 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ceftriaxone |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20091105 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | CEFTRIAXONE SODIUM |
Strength Number | 2 |
Strength Unit | g/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |